US Biomax - Lung Cancer Tissue Array With Normal Lung Tissue, Including TNM, Clinical Stage And Pathology Grade, 120 Cases/120 Cores, Replacing BC041115

Lung Sub-types (135)

Paraffin Embedded Tissue Array Types [view all]

Human

BC041115a

Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases/120 cores, replacing BC041115

Unstained: $255.00

H&E (BC041115as*): $255.00

Microarray Panel:	Lung adenocarcinoma tissue microarray with normal lung tissue, containing 41 cases of lung squamous cell carcinoma, 2 lung adenosquamous carcinoma, 48 lung adenocarcinoma, 4 each of lung bronchioloalveolar carcinoma and large cell carcinoma, 6 small cell undifferentiated carcinoma, 5 carcinoid, plus 10 normal lung tissue, single core per case
Cores:	120
Cases:	120
Layout:	12 cols × 10 rows
Core Diameter:	1 mm
Thickness:	5 µm
Quality Control:	Anti-Actin confirmed
Applications:	Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:	Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

Unstained: unstained paraffin tissue microarray slide.
Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

Slide Label: US Biomax, Inc. Tissue Array

	1	2	3	4	5	6	7	8	9	10	11	12
A
B
C
D
E
F
G
H
I
J

Legend:

Lun - Lung

- Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIIb), - Malignant tumor (stage IV), - Normal tissue

Specification Sheet

Pos	No.	Sex	Age	Organ	Pathology diagnosis	Grade	Stage	TNM	Type †
A1	1	M	65	Lung	Squamous cell carcinoma	2	IIIa	T3N1M0	Malignant
A2	2	M	65	Lung	Squamous cell carcinoma	1	IIIa	T3N0M0	Malignant
A3	3	M	53	Lung	Squamous cell carcinoma with necrosis	2	II	T2N1M0	Malignant
A4	4	M	46	Lung	Squamous cell carcinoma	1	IIIa	T3N0M0	Malignant
A5	5	M	68	Lung	Squamous cell carcinoma	1	II	T2N1M0	Malignant
A6	6	F	43	Lung	Squamous cell carcinoma	1	II	T2N1M0	Malignant
A7	7	M	57	Lung	Squamous cell carcinoma	2	IIIa	T3N2M0	Malignant
A8	8	M	57	Lung	Squamous cell carcinoma (sparse)	–	I	T2N0M0	Malignant
A9	9	F	68	Lung	Squamous cell carcinoma with necrosis	2	II	T2N1M0	Malignant
A10	10	M	69	Lung	Squamous cell carcinoma with necrosis	2	I	T2N0M0	Malignant
A11	11	M	69	Lung	Squamous cell carcinoma	1	IIIa	T2N2M0	Malignant
A12	12	M	66	Lung	Squamous cell carcinoma	1	I	T2N0M0	Malignant
B1	13	M	47	Lung	Squamous cell carcinoma	2	I	T1N0M0	Malignant
B2	14	F	50	Lung	Squamous cell carcinoma	2	I	T2N0M0	Malignant
B3	15	M	44	Lung	Squamous cell carcinoma	2	II	T2N1M0	Malignant
B4	16	M	50	Lung	Squamous cell carcinoma	2	IIIa	T3N1M0	Malignant
B5	17	M	63	Lung	Squamous cell carcinoma	1	IIIa	T3N1M0	Malignant
B6	18	M	46	Lung	Squamous cell carcinoma	1	I	T2N0M0	Malignant
B7	19	M	43	Lung	Squamous cell carcinoma	2	I	T2N0M0	Malignant
B8	20	M	68	Lung	Squamous cell carcinoma	2	IIIa	T2N2M0	Malignant
B9	21	M	65	Lung	Squamous cell carcinoma	2	I	T2N0M0	Malignant
B10	22	M	51	Lung	Squamous cell carcinoma	2	I	T2N0M0	Malignant
B11	23	M	55	Lung	Squamous cell carcinoma	2	I	T2N0M0	Malignant
B12	24	M	41	Lung	Squamous cell carcinoma (chronic inflammation of fibrous tissue and blood vessel)	–	IIIa	T2N2M0	Malignant
C1	25	M	66	Lung	Squamous cell carcinoma	2	I	T2N0M0	Malignant
C2	26	M	61	Lung	Squamous cell carcinoma	2	I	T2N0M0	Malignant
C3	27	M	63	Lung	Squamous cell carcinoma	2	IIIa	T3N2M0	Malignant
C4	28	M	63	Lung	Squamous cell carcinoma	2	I	T2N0M0	Malignant
C5	29	M	51	Lung	Squamous cell carcinoma	2	IIIa	T3N0M0	Malignant
C6	30	M	61	Lung	Squamous cell carcinoma	3	IIIa	T3N1M0	Malignant
C7	31	M	66	Lung	Squamous cell carcinoma	2	II	T2N1M0	Malignant
C8	32	M	66	Lung	Squamous cell carcinoma	2	IIIa	T3N1M0	Malignant
C9	33	F	60	Lung	Squamous cell carcinoma	2	II	T2N1M0	Malignant
C10	34	M	56	Lung	Squamous cell carcinoma	3	II	T1N2M0	Malignant
C11	35	F	51	Lung	Squamous cell carcinoma (interstitial pneumonia)	–	IIIa	T2N2M0	Malignant
C12	36	M	46	Lung	Squamous cell carcinoma	2	I	T2N0M0	Malignant
D1	37	M	60	Lung	Squamous cell carcinoma	3	I	T2N0M0	Malignant
D2	38	M	44	Lung	Squamous cell carcinoma	3	I	T2N0M0	Malignant
D3	39	M	65	Lung	Squamous cell carcinoma with necrosis	2	I	T2N0M0	Malignant
D4	40	M	71	Lung	Squamous cell carcinoma	2	I	T1N0M0	Malignant
D5	41	M	61	Lung	Squamous cell carcinoma	2	I	T2N0M0	Malignant
D6	42	M	52	Lung	Adenosquamous carcinoma	–	I	T2N0M0	Malignant
D7	43	F	43	Lung	Adenosquamous carcinoma	–	I	T2N0M0	Malignant
D8	44	M	50	Lung	Mucinous adenocarcinoma	1	II	T2N1M0	Malignant
D9	45	M	70	Lung	Papillary adenocarcinoma	1	I	T1N0M0	Malignant
D10	46	M	42	Lung	Mucinoius adenocarcinoma	1	I	T2N0M0	Malignant
D11	47	F	48	Lung	Mucinoius adenocarcinoma	1	I	T2N0M0	Malignant
D12	48	F	64	Lung	Mucinoius adenocarcinoma	1	II	T2N1M0	Malignant
E1	49	F	62	Lung	Adenocarcinoma	3	II	T2N1M0	Malignant
E2	50	F	44	Lung	Adenocarcinoma	1	IIIa	T3N1M0	Malignant
E3	51	F	43	Lung	Adenocarcinoma with necrosis	2	IIIa	T2N2M0	Malignant
E4	52	M	63	Lung	Adenocarcinoma	2	IIIa	T3N2M0	Malignant
E5	53	M	51	Lung	Adenocarcinoma	2	IIIa	T3N1M0	Malignant
E6	54	F	63	Lung	Adenocarcinoma	2	II	T2N1M0	Malignant
E7	55	M	50	Lung	Adenocarcinoma	2	IIIa	T3N1M0	Malignant
E8	56	F	44	Lung	Adenocarcinoma	2	II	T2N1M0	Malignant
E9	57	M	56	Lung	Adenocarcinoma	2	IIIa	T3N0M0	Malignant
E10	58	F	71	Lung	Adenocarcinoma	2	II	T2N1M0	Malignant
E11	59	F	56	Lung	Adenocarcinoma	1	II	T2N1M0	Malignant
E12	60	F	50	Lung	Papillary adenocarcinoma	1	I	T2N0M0	Malignant
F1	61	F	56	Lung	Adenocarcinoma	2	I	T1N0M0	Malignant
F2	62	M	67	Lung	Adenocarcinoma (sparse)	2	II	T2N1M0	Malignant
F3	63	M	59	Lung	Adenocarcinoma	2	IIIa	T3N1M0	Malignant
F4	64	M	61	Lung	Adenocarcinoma	2	I	T2N0M0	Malignant
F5	65	M	50	Lung	Adenocarcinoma	2	I	T2N0M0	Malignant
F6	66	F	61	Lung	Adenocarcinoma	2	II	T2N1M0	Malignant
F7	67	F	60	Lung	Adenocarcinoma	2	I	T1N0M0	Malignant
F8	68	M	66	Lung	Adenocarcinoma	2	II	T2N1M0	Malignant
F9	69	F	68	Lung	Adenocarcinoma with necrosis	2	IIIa	T3N1M0	Malignant
F10	70	F	55	Lung	Adenocarcinoma	2	I	T2N0M0	Malignant
F11	71	F	50	Lung	Adenocarcinoma	2	IIIa	T3N1M0	Malignant
F12	72	M	57	Lung	Adenocarcinoma	2	II	T2N1M0	Malignant
G1	73	M	50	Lung	Adenocarcinoma	2–3	II	T2N1M0	Malignant
G2	74	M	68	Lung	Adenocarcinoma	2–3	IV	T2N1M1	Malignant
G3	75	M	60	Lung	Adenocarcinoma	2–3	II	T2N1M0	Malignant
G4	76	F	51	Lung	Adenocarcinoma	2–3	I	T2N0M0	Malignant
G5	77	M	68	Lung	Adenocarcinoma	2	II	T2N1M0	Malignant
G6	78	F	64	Lung	Adenocarcinoma	2–3	I	T2N0M0	Malignant
G7	79	F	59	Lung	Adenocarcinoma (sparse)	–	IIIa	T3N1M0	Malignant
G8	80	M	53	Lung	Adenocarcinoma	3	I	T2N0M0	Malignant
G9	81	F	57	Lung	Adenocarcinoma	2	I	T2N0M0	Malignant
G10	82	F	48	Lung	Adenocarcinoma	2–3	I	T2N0M0	Malignant
G11	83	M	60	Lung	Adenocarcinoma	3	IIIa	T2N2M0	Malignant
G12	84	M	54	Lung	Adenocarcinoma	3	I	T2N0M0	Malignant
H1	85	M	76	Lung	Adenocarcinoma	3	II	T2N1M0	Malignant
H2	86	M	67	Lung	Adenocarcinoma	3	IIIa	T3N0M0	Malignant
H3	87	F	35	Lung	Adenocarcinoma	3	I	T2N0M0	Malignant
H4	88	F	68	Lung	Adenocarcinoma	3	IIIa	T2N2M0	Malignant
H5	89	M	57	Lung	Adenocarcinoma (lung tissue)	–	I	T2N0M0	Malignant
H6	90	M	42	Lung	Adenocarcinoma	3	IIIa	T3N1M0	Malignant
H7	91	M	59	Lung	Adenocarcinoma	2	II	T2N1M0	Malignant
H8	92	F	51	Lung	Bronchioloalveolar carcinoma	–	I	T2N0M0	Malignant
H9	93	M	72	Lung	Bronchioloalveolar carcinoma	–	I	T1N0M0	Malignant
H10	94	M	60	Lung	Bronchioloalveolar carcinoma (carcinoma sparse with necrosis)	–	II	T2N1M0	Malignant
H11	95	M	53	Lung	Bronchioloalveolar carcinoma	–	II	T2N1M0	Malignant
H12	96	M	53	Lung	Large cell carcinoma	–	IIIb	T4N0M0	Malignant
I1	97	F	54	Lung	Large cell carcinoma	–	II	T2N1M0	Malignant
I2	98	M	54	Lung	Large cell carcinoma	–	I	T2N0M0	Malignant
I3	99	M	65	Lung	Large cell carcinoma	–	I	T2N0M0	Malignant
I4	100	F	51	Lung	Small cell undifferentiated carcinoma	–	I	T1N0M0	Malignant
I5	101	M	39	Lung	Small cell undifferentiated carcinoma	–	II	T2N1M0	Malignant
I6	102	F	42	Lung	Small cell undifferentiated carcinoma	–	IIIb	T4N1M0	Malignant
I7	103	M	73	Lung	Small cell undifferentiated carcinoma	–	IIIa	T3N1M0	Malignant
I8	104	F	32	Lung	Small cell undifferentiated carcinoma	–	II	T1N1M0	Malignant
I9	105	M	61	Lung	Small cell undifferentiated carcinoma	–	I	T2N0M0	Malignant
I10	106	M	60	Lung	Atypical carcinoid	–	I	T1N0M0	Malignant
I11	107	M	57	Lung	Atypical carcinoid	–	I	T1N0M0	Malignant
I12	108	F	36	Lung	Atypical carcinoid	–	I	T2N0M0	Malignant
J1	109	M	49	Lung	Atypical carcinoid	–	IIIb	T4N2M0	Malignant
J2	110	M	43	Lung	Carcinoid	–	I	T2N0M0	Malignant
J3	111	M	46	Lung	Normal lung tissue	–	–	–	Normal
J4	112	F	14	Lung	Normal lung tissue	–	–	–	Normal
J5	113	M	47	Lung	Normal lung tissue	–	–	–	Normal
J6	114	M	42	Lung	Normal lung tissue	–	–	–	Normal
J7	115	M	25	Lung	Normal lung tissue	–	–	–	Normal
J8	116	M	35	Lung	Normal lung tissue	–	–	–	Normal
J9	117	F	15	Lung	Normal lung tissue	–	–	–	Normal
J10	118	M	50	Lung	Normal lung tissue	–	–	–	Normal
J11	119	M	47	Lung	Normal lung tissue	–	–	–	Normal
J12	120	M	24	Lung	Normal lung tissue	–	–	–	Normal
–	–	F	55	liver	Hepatocellular liver cancer (tissue marker)	3		T3N0M0	Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:

Paraffin Embedded Tissue Array Types [view all]

Human

Cell Arrays (2)

Mouse (16)

Rat (9)

Monkey (5)

Frozen Tissue Arrays (54)

BC041115a

*Tissue Microarray Slide Types:

Microarray Panel Display

Specification Sheet

TNM grading: